卡介苗-谷氨酰胺疫苗预防儿童结核分枝杆菌感染的效果:一项最新的系统评价和荟萃分析

IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES
Shunli Cai , Qingyi Luo , Guozhong Zhou , Xin Guo , Yan Dong , Hongbo Chen , Shiqi Luo , Jian He , Yuan Xia , Hanse Li , Yingchen Zhou , Chao Song
{"title":"卡介苗-谷氨酰胺疫苗预防儿童结核分枝杆菌感染的效果:一项最新的系统评价和荟萃分析","authors":"Shunli Cai ,&nbsp;Qingyi Luo ,&nbsp;Guozhong Zhou ,&nbsp;Xin Guo ,&nbsp;Yan Dong ,&nbsp;Hongbo Chen ,&nbsp;Shiqi Luo ,&nbsp;Jian He ,&nbsp;Yuan Xia ,&nbsp;Hanse Li ,&nbsp;Yingchen Zhou ,&nbsp;Chao Song","doi":"10.1016/j.ijid.2025.107909","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To update the understanding of the effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine in preventing tuberculosis (TB) infection in children.</div></div><div><h3>Methods</h3><div>PubMed, Web of Science, Cochrane, and Embase were searched from their inception to January 12, 2025. Studies were included if they focused on children under 19 years exposed to pulmonary TB, used interferon-gamma release assays (IGRA) for infection assessment, and reported IGRA-positive outcomes for both BCG and non-BCG groups. Pooled estimates were derived using random-effects meta-analysis, with heterogeneity assessed by the <em>I²</em> statistic.</div></div><div><h3>Results</h3><div>Total 8242 participants were enrolled in 32 studies. The overall protective effectiveness of BCG against infection was 18%, with a relative risk [RR] of 0.82 (95% confidence interval [CI]: 0.73-0.91], <em>I²</em> = 60%). Subgroup analysis revealed a higher effectiveness of 29% (RR = 0.71 [95% CI: 0.62-0.82], <em>I²</em> = 41%) in low-TB incidence areas, while effectiveness was not significant (RR = 0.95 [95% CI: 0.84-1.09], <em>I²</em> = 55%) in high-TB incidence areas.</div></div><div><h3>Conclusions</h3><div>BCG vaccination shows protective effectiveness against TB infection, particularly in low-TB incidence areas. Its effectiveness in high-TB incidence areas remains uncertain, underscoring the need for further research to optimize vaccination strategies in these settings.</div></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":"156 ","pages":"Article 107909"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis\",\"authors\":\"Shunli Cai ,&nbsp;Qingyi Luo ,&nbsp;Guozhong Zhou ,&nbsp;Xin Guo ,&nbsp;Yan Dong ,&nbsp;Hongbo Chen ,&nbsp;Shiqi Luo ,&nbsp;Jian He ,&nbsp;Yuan Xia ,&nbsp;Hanse Li ,&nbsp;Yingchen Zhou ,&nbsp;Chao Song\",\"doi\":\"10.1016/j.ijid.2025.107909\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><div>To update the understanding of the effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine in preventing tuberculosis (TB) infection in children.</div></div><div><h3>Methods</h3><div>PubMed, Web of Science, Cochrane, and Embase were searched from their inception to January 12, 2025. Studies were included if they focused on children under 19 years exposed to pulmonary TB, used interferon-gamma release assays (IGRA) for infection assessment, and reported IGRA-positive outcomes for both BCG and non-BCG groups. Pooled estimates were derived using random-effects meta-analysis, with heterogeneity assessed by the <em>I²</em> statistic.</div></div><div><h3>Results</h3><div>Total 8242 participants were enrolled in 32 studies. The overall protective effectiveness of BCG against infection was 18%, with a relative risk [RR] of 0.82 (95% confidence interval [CI]: 0.73-0.91], <em>I²</em> = 60%). Subgroup analysis revealed a higher effectiveness of 29% (RR = 0.71 [95% CI: 0.62-0.82], <em>I²</em> = 41%) in low-TB incidence areas, while effectiveness was not significant (RR = 0.95 [95% CI: 0.84-1.09], <em>I²</em> = 55%) in high-TB incidence areas.</div></div><div><h3>Conclusions</h3><div>BCG vaccination shows protective effectiveness against TB infection, particularly in low-TB incidence areas. Its effectiveness in high-TB incidence areas remains uncertain, underscoring the need for further research to optimize vaccination strategies in these settings.</div></div>\",\"PeriodicalId\":14006,\"journal\":{\"name\":\"International Journal of Infectious Diseases\",\"volume\":\"156 \",\"pages\":\"Article 107909\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1201971225001328\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971225001328","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

目的提高对卡介苗预防儿童结核(TB)感染效果的认识。方法检索spubmed、Web of Science、Cochrane和Embase自成立至2025年1月12日的文献。如果研究的重点是暴露于肺结核的19岁以下儿童,使用干扰素- γ释放法(IGRA)进行感染评估,并报告卡介苗组和非卡介苗组的IGRA阳性结果,则纳入研究。采用随机效应荟萃分析得出汇总估计值,通过I²统计量评估异质性。结果32项研究共纳入8242名受试者。卡介苗对感染的总体保护效力为18%,相对危险度[RR]为0.82(95%可信区间[CI]: 0.73-0.91], I²= 60%)。亚组分析显示,低结核病发病率地区的疗效较高,为29% (RR = 0.71 [95% CI: 0.62-0.82], I²= 41%),而高结核病发病率地区的疗效不显著(RR = 0.95 [95% CI: 0.84-1.09], I²= 55%)。结论卡介苗接种对结核病感染具有保护作用,特别是在结核病低发病率地区。它在结核病高发地区的有效性仍然不确定,强调需要进一步研究以优化这些地区的疫苗接种策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis

Objectives

To update the understanding of the effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine in preventing tuberculosis (TB) infection in children.

Methods

PubMed, Web of Science, Cochrane, and Embase were searched from their inception to January 12, 2025. Studies were included if they focused on children under 19 years exposed to pulmonary TB, used interferon-gamma release assays (IGRA) for infection assessment, and reported IGRA-positive outcomes for both BCG and non-BCG groups. Pooled estimates were derived using random-effects meta-analysis, with heterogeneity assessed by the statistic.

Results

Total 8242 participants were enrolled in 32 studies. The overall protective effectiveness of BCG against infection was 18%, with a relative risk [RR] of 0.82 (95% confidence interval [CI]: 0.73-0.91], = 60%). Subgroup analysis revealed a higher effectiveness of 29% (RR = 0.71 [95% CI: 0.62-0.82], = 41%) in low-TB incidence areas, while effectiveness was not significant (RR = 0.95 [95% CI: 0.84-1.09], = 55%) in high-TB incidence areas.

Conclusions

BCG vaccination shows protective effectiveness against TB infection, particularly in low-TB incidence areas. Its effectiveness in high-TB incidence areas remains uncertain, underscoring the need for further research to optimize vaccination strategies in these settings.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
18.90
自引率
2.40%
发文量
1020
审稿时长
30 days
期刊介绍: International Journal of Infectious Diseases (IJID) Publisher: International Society for Infectious Diseases Publication Frequency: Monthly Type: Peer-reviewed, Open Access Scope: Publishes original clinical and laboratory-based research. Reports clinical trials, reviews, and some case reports. Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases. Emphasizes diseases common in under-resourced countries.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信